ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $6,714,000 | -37.8% | 212,743 | -20.2% | 0.03% | -37.7% |
Q4 2021 | $10,787,000 | +13.5% | 266,543 | -2.2% | 0.05% | +6.0% |
Q3 2021 | $9,506,000 | +28.8% | 272,607 | +1.4% | 0.05% | +31.6% |
Q2 2021 | $7,379,000 | +19.9% | 268,711 | +22.6% | 0.04% | +11.8% |
Q1 2021 | $6,153,000 | +21.8% | 219,125 | +12.6% | 0.03% | +13.3% |
Q4 2020 | $5,050,000 | +242.6% | 194,539 | +126.2% | 0.03% | +200.0% |
Q3 2020 | $1,474,000 | – | 86,014 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |